INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Glenmark Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532296	ISIN Demat INE935A01035	Book Value 848.31	NSE Symbol GLENMARK	Dividend Yield (%) 0.13	Market Cap (₹ Cr.) 55,707.85	P/E 37.86	EPS 52.14	Face Value 1

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	1219.53	2178.9	1909.94	2208.84
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,219.53	2,178.90	1,909.94	2,208.84
Other Operating Income	319.13	216.03	99.56	42.44
Total Income from operations (net)	1,538.66	2,394.93	2,009.49	2,251.28
Total Expenses	1,775.59	1,724.41	1,724.50	1,812.52
Cost of Sales	656.28	718.16	786.12	784.89
Employee Cost	453.68	408.44	382.70	427.98
Depreciation, amortization and depletion expense	58.93	57.64	55.53	55.16
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	606.70	540.17	500.15	544.48
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	-236.93	670.52	285.00	438.76
Other Income	285.76	69.34	88.45	129.19
Profit from ordinary activities before finance costs and exceptional items	48.82	739.86	373.45	567.95
Finance Costs	23.40	15.46	13.13	8.46
Profit from ordinary activities after finance costs but before exceptional items	25.43	724.40	360.32	559.49
Exceptional Items	-931.79	-323.23	-179.17	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	-906.37	401.17	181.16	559.49
Total Tax	-167.18	70.94	33.40	145.69
Net profit from Ordinary Activities After Tax	-739.19	330.23	147.76	413.80
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	-739.19	330.23	147.76	413.80
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	-739.19	330.23	147.76	413.80
Other Comprehensive Income	-14.62	-0.53	-3.00	-0.53
Total Comprehensive Income	-753.81	329.69	144.76	413.27
Equity	28.22	28.22	28.22	28.22
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	6.82	23.15	11.59	14.66
EPS before Exceptional/Extraordinary items-Diluted	6.82	23.15	11.59	14.66
EPS after Exceptional/Extraordinary items-Basic	-26.19	11.70	5.24	14.66
EPS after Exceptional/Extraordinary items-Diluted	-26.19	11.70	5.24	14.66
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00